Pathfinders in Biopharma

Innovation and an Aging Population Drive MedTech


Listen Later

The MedTech sector continues to grow in the U.S. as innovation in patient treatments and delivery meets increased demand from an aging population. Medical technology analyst Shagun Singh assesses key data points from the RBC Capital Markets’ Doctor Days events, looking at how the healthcare sector can empower investors to position themselves for future growth.

...more
View all episodesView all episodes
Download on the App Store

Pathfinders in BiopharmaBy RBC Capital Markets

  • 5
  • 5
  • 5
  • 5
  • 5

5

12 ratings


More shows like Pathfinders in Biopharma

View all
Motley Fool Money by The Motley Fool

Motley Fool Money

3,235 Listeners

WSJ Your Money Briefing by The Wall Street Journal

WSJ Your Money Briefing

1,720 Listeners

Exchanges by Goldman Sachs

Exchanges

962 Listeners

Odd Lots by Bloomberg

Odd Lots

1,985 Listeners

WSJ Tech News Briefing by The Wall Street Journal

WSJ Tech News Briefing

1,654 Listeners

The a16z Show by Andreessen Horowitz

The a16z Show

1,095 Listeners

The Long Run with Luke Timmerman by Timmerman Report

The Long Run with Luke Timmerman

124 Listeners

The Readout Loud by STAT

The Readout Loud

334 Listeners

Wall Street Breakfast by Seeking Alpha

Wall Street Breakfast

1,050 Listeners

Thoughts on the Market by Morgan Stanley

Thoughts on the Market

1,301 Listeners

The Journal. by The Wall Street Journal & Spotify Studios

The Journal.

6,088 Listeners

BioCentury This Week by BioCentury

BioCentury This Week

35 Listeners

RBC's Markets in Motion by RBC Capital Markets

RBC's Markets in Motion

41 Listeners

Biotech Hangout by Daphne Zohar, Josh Schimmer, Brad Loncar, Tim Opler & more

Biotech Hangout

21 Listeners

Industries in Motion by RBC Capital Markets

Industries in Motion

10 Listeners

Powering Sustainable Ideas by RBC Capital Markets

Powering Sustainable Ideas

0 Listeners

The Markets by Goldman Sachs

The Markets

78 Listeners

Strategic Alternatives by RBC Capital Markets

Strategic Alternatives

17 Listeners

The Top Line by Fierce Life Sciences

The Top Line

16 Listeners

Macro Minutes by RBC Capital Markets

Macro Minutes

3 Listeners